A multicenter, randomized, double-blind, placebo-controlled study of a combination of levonorgestrel and ethinyl estradiol in a continuous daily regimen in subjects with premenstrual dysphoric disorder
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ethinylestradiol/levonorgestrel (Primary)
- Indications Premenstrual dysphoric disorder
- Focus Therapeutic Use
- 27 Dec 2007 Biomarkers information updated
- 26 Dec 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 10 Jul 2007 Status change from recruiting to in progress